Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

NCT00262886 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: graft-versus-tumor induction therapy
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
DRUG: tacrolimus
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of Rochester